REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/30/2025
Back to search
Official data from USPTO
SAMPLE TO OUTCOME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SAMPLE TO OUTCOME
ST13
US500000079264602Class
9, 10
Filing
79264602
Registration
6087728
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
07/01/2025
Trademark type
Word
Nice classes
9, 10
Filing date
05/21/2019
Registration date
06/30/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/30/2020
Last transaction
07/01/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
DE
Examiner
GUROK, GALINA
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Qiagen GmbH
Representatives
Keith A. Weltsch Scully, Scott, Murphy & Presser, P.C.
Technical classification
Nice Classes
Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable and recorded computer software for data and document managementmedical teaching; downloadable and recorded computer software and related databases for use in preparing and managing nucleic acid and protein assay analysis and for managing quality controlvalidationinterpretationreportingclinical decision supportdata managementintegration with medical recordsphysician portalslaboratory networkingprofessional healthcare and trial matching services all related to molecular and genomic analysis; downloadable and recorded computer softwareevidence-based decision support software used as an aid in the interpretation of variants observed in genomic sequencing data; downloadable and recorded computer software for evaluation of genomic variants in the context of software for searching and allocating published biomedical literatureprofessional association guidelinespublicly available databases and annotationsdrug labelsand/or clinical-trials; downloadable and recorded computer software for preparinginterpretation and managing of bioinformatics analysesoptionally combined with data managementgraphical viewing and output options; downloadable and recorded computer programs and software for biological data mining; downloadable and recorded computer programs and software for developing bioinformatics database for others; bio-chips for research or scientific purposes; DNA-chips; RNA-chips; next-generation sequencing (NGS) data processor; bioinformatics data processor; computer hardware and downloadable and recorded computer software for collectingstoringanalyzingvisualizinginterpreting bioinformaticsgenomicsphenomics data sets; computer hardware and downloadable and recorded computer software for the monitoring of pathogens; downloadable computer databases for bioinformaticsgenomicsphenomicsmicrobiomemetagenomicsorganism-and -pathogen-specific genotype recordsorganism and pathogen-specific phenotype information; downloadable and recorded computer software for use in the integrationanalysis and visualization of biomedically relevant information allowing users to explore compoundtargetassaybiological pathway and disease information; downloadable and recorded computer software and databases for the analysis of genomesexomestargeted ampliconstranscriptomesepigenetic NGS sequencing data; downloadable and recorded computer softwaresoftware development toolsvisualization software modulesfor analysisdiscoveryverificationvalidation of disease biomarkers
Class 10
Medical diagnostic testing instruments for processing and analysis of genetic samples primarily for single-cell genomictranscriptomicproteomic analysis; medical and diagnostic apparatus for testing DNA and RNA samplesusing gene expression testsgene expression profiling assaysgenetic information and dataprotein biomarkersclinical dataand/or demographic information; testing apparatus for medical purposes for testing DNA and RNA samples sold as a unit with downloadable bioinformatics and machine learning algorithm software and medical data software to support treatment decisions; medical testing apparatus for testing DNA and RNA samples and quantifying biomarker levels and relative expression of host response genes; medical apparatus and instruments for detecting tumor cancerheredity and genetic diseases; medical testing apparatus for samples of body fluidstissue and organs; genome machine for medical purposesapparatus for DNA and RNA medical testing; diagnostic apparatus for the detection of cancergenetic or heredity diseases
Publications
History of USPTO decisions and trademark events.
22 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/10/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/24/2020
FIMP
FINAL DISPOSITION PROCESSED
10/23/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/30/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
06/30/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/14/2020
PUBO
PUBLISHED FOR OPPOSITION
04/14/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/25/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/04/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/04/2020
RFNT
REFUSAL PROCESSED BY IB
09/20/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/04/2019
RFRR
REFUSAL PROCESSED BY MPU
09/04/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/21/2019
CNRT
NON-FINAL ACTION WRITTEN
08/20/2019
MAFR
APPLICATION FILING RECEIPT MAILED
08/20/2019
DOCK
ASSIGNED TO EXAMINER
08/16/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/16/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/08/2019
Continuous trademark protection
Get notified about every new filing that threatens SAMPLE TO OUTCOME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.